QUETIAPINE SUN LP 50 mg, extended-release tablet 30 tablets
Active ingredients: Quetiapine fumarate, Quetiapine
Commercialized according to BDPMANSM noticeDispensing in France: Prescription only
Extended-release tablet30 tabletsorale
Supply disruption
Package details
Original BDPM fields are shown in French.
- Official name
- QUETIAPINE SUN LP 50 mg, comprimé à libération prolongée
- Pharmaceutical form
- comprimé à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC polychlortrifluoroéthylène aluminium de 30 comprimé(s)
- Marketing authorisation holder
- SUN PHARMA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 24 Jun 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
62333104CIP73004565CIP133400930045657Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE QUÉTIAPINEcomprimé | — | SA |
| QUÉTIAPINEcomprimé | 50 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.